Voltage-sensing phosphatase modulation by a C2 domain by Paul M. Castle et al.
ORIGINAL RESEARCH
published: 08 April 2015
doi: 10.3389/fphar.2015.00063
Frontiers in Pharmacology | www.frontiersin.org 1 April 2015 | Volume 6 | Article 63
Edited by:
Carlos Alberto Villalba-Galea,
Virginia Commonwealth University
School of Medicine, USA
Reviewed by:
Nazzareno D’Avanzo,
Université de Montréal, Canada
Nick Reid Leslie,
Heriot Watt University, UK
*Correspondence:
Susy C. Kohout,
Department of Cell Biology and
Neuroscience, Montana State
University, 2B Lewis Hall, Bozeman,
MT 59717, USA
skohout@montana.edu
Specialty section:
This article was submitted to
Pharmacology of Ion Channels and
Channelopathies, a section of the
journal Frontiers in Pharmacology
Received: 15 January 2015
Accepted: 10 March 2015
Published: 08 April 2015
Citation:
Castle PM, Zolman KD and Kohout
SC (2015) Voltage-sensing
phosphatase modulation by a C2
domain. Front. Pharmacol. 6:63.
doi: 10.3389/fphar.2015.00063
Voltage-sensing phosphatase
modulation by a C2 domain
Paul M. Castle, Kevin D. Zolman and Susy C. Kohout *
Department of Cell Biology and Neuroscience, Montana State University, Bozeman, MT, USA
The voltage-sensing phosphatase (VSP) is the first example of an enzyme controlled
by changes in membrane potential. VSP has four distinct regions: the transmembrane
voltage-sensing domain (VSD), the inter-domain linker, the cytosolic catalytic domain,
and the C2 domain. The VSD transmits the changes in membrane potential through
the inter-domain linker activating the catalytic domain which then dephosphorylates
phosphatidylinositol phosphate (PIP) lipids. The role of the C2, however, has not been
established. In this study, we explore two possible roles for the C2: catalysis and
membrane-binding. The Ci-VSP crystal structures show that the C2 residue Y522
lines the active site suggesting a contribution to catalysis. When we mutated Y522 to
phenylalanine, we found a shift in the voltage dependence of activity. This suggests
hydrogen bonding as a mechanism of action. Going one step further, when we deleted
the entire C2 domain, we found voltage-dependent enzyme activity was no longer
detectable. This result clearly indicates the entire C2 is necessary for catalysis as well
as for modulating activity. As C2s are known membrane-binding domains, we tested
whether the VSP C2 interacts with the membrane. We probed a cluster of four positively
charged residues lining the top of the C2 and suggested by previous studies to interact
with phosphatidylinositol 4,5-bisphosphate [PI(4,5)P2] (Kalli et al., 2014). Neutralizing
those positive charges significantly shifted the voltage dependence of activity to higher
voltages. We tested membrane binding by depleting PI(4,5)P2 from the membrane
using the 5HT2C receptor and found that the VSD motions as measured by voltage
clamp fluorometry (VCF) were not changed. These results suggest that if the C2 domain
interacts with the membrane to influence VSP function it may not occur exclusively
through PI(4,5)P2. Together, this data advances our understanding of the VSP C2 by
demonstrating a necessary and critical role for the C2 domain in VSP function.
Keywords: voltage-sensing phosphatase, C2 domain, PIP, PH domains, voltage clamp fluorometry, membrane
potential
Introduction
The voltage-sensing phosphatase (VSP) is the first enzyme controlled by the membrane poten-
tial of the cell (Murata et al., 2005). Like all voltage-regulated proteins, VSP has a voltage-
sensing domain (VSD) with four transmembrane helices and sensing charges on the fourth helix,
S4. The phosphatase domain of VSP is homologous to the “phosphatase and tensin homolog
deleted on chromosome 10” (PTEN) protein, a lipid and protein phosphatase (Murata et al.,
2005; Okamura and Dixon, 2011; Villalba-Galea, 2012). The VSP phosphatase domain can be
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separated into three regions of interest; the inter-domain linker,
the catalytic domain, and the C2 domain (Figure 1A). The
linker has been implicated in coupling the VSD to the phos-
phatase domain in a lipid-dependent manner (Murata et al.,
2005; Villalba-Galea et al., 2009; Kohout et al., 2010; Hobiger
et al., 2012, 2013; Liu et al., 2012). The VSP catalytic domain is
44% identical with that of PTEN which fueled the assumption
that VSP and PTEN catalyze the same reaction, dephosphory-
lating phosphatidylinositol 3,4,5-trisphosphate [PI(3,4,5)P3] at
the 3-position (Murata et al., 2005). Subsequent studies have
found VSP dephosphorylates three different phosphatidylinosi-
tol phosphate (PIP) substrates at two positions: PI(3,4,5)P3 and
PI(4,5)P2 at the 5-phosphate as well as phosphatidylinositol 3,4-
bisphosphate [PI(3,4)P2] at the 3-phosphate, all in a voltage-
dependent manner (Figure 1B) (Iwasaki et al., 2008; Halaszovich
et al., 2009; Kurokawa et al., 2012). The potential dephosphoryla-
tion of PI(3,4,5)P3 at the 3-phosphate by VSP remains unsettled.
Even so, VSP clearly has a broader activity range than PTEN,
and as a result, could have an even broader impact on PIP
regulation.
PIP regulation is critical to a large number of cellular processes
including cell proliferation, migration, development, synaptic
regulation, ion channel modulation, and others (Di Paolo and
De Camilli, 2006; Logothetis et al., 2010; Koch and Holt, 2012;
Balla, 2013). PIP concentrations are tightly controlled and a small
deviation initiates the up- or down-regulation of the appropri-
ate kinase or phosphatase to take the concentrations back to
normal levels. Several human diseases are linked to mutations
in PIP-metabolizing enzymes, including cancers, peripheral neu-
ropathy, Alzheimer’s, and psychiatric disorders such as bipolar
disorder (Simpson and Parsons, 2001; Di Paolo and De Camilli,
2006;McCrea andDeCamilli, 2009; Aguissa-Touré and Li, 2012).
Because of the role different PIPs play in both normal cellu-
lar regulation and in disease states, it is crucial to understand
how all PIPs are interconverted. The role of VSP in this pro-
cess is particularly important since it serves as both a 5- and a
3-phosphatase.
Much of the VSP research focus has been on the VSD, linker
and the catalytic domains, leaving the contribution of the VSP
C2 domain unclear (Figure 1A). Traditionally, C2 domains are
independently folded, lipid-binding domains (Lemmon, 2008).
While C2s are not well-conserved on the sequence level, they
are very well-conserved on the structural level, having a charac-
teristic eight-stranded anti-parallel β-sandwich with three loops
on one end responsible for binding calcium [Ca2+-binding loops
(CBLs) 1–3] (Nalefski and Falke, 1996; Lemmon, 2008). The VSP
C2 does not have the required aspartic acids for binding Ca2+
so it is unlikely to be regulated by Ca2+, much like the Ca2+
independent C2 of PTEN. Not all C2s bind Ca2+ yet many still
play a role in signaling, including membrane-binding (Corbalán-
García et al., 2003; Sánchez-Bautista et al., 2007) and mediating
protein–protein interactions (Johnson et al., 1996; Schechtman
et al., 2004) as well as regulating ion channels (Miki et al., 2007).
Hence even without the ability to bind Ca2+, C2s are actively
involved in signaling.
The VSP high-resolution crystal structures suggest a new
potential role for C2 domains—contributing to catalysis. A
tyrosine (Tyr) from the C2 (Y522) was found physically in the
active site of the catalytic domain (Matsuda et al., 2011; Liu et al.,
2012). Supporting that hypothesis, the mutation Y522A altered
catalysis by slowing down the rate of 3-phosphate dephospho-
rylation of PI(3,4)P2 (Liu et al., 2012). The recent cloning of
salamander VSP also suggests the VSP C2 domains are impor-
tant since it is missing part of the C2 and is catalytically dead
(Mutua et al., 2014). However, very little is known regarding the
contributions and mechanisms of the VSP C2.
To fill that gap, we investigated how the VSP C2 domain
contributes to function by deleting the entire C2 domain as
well as mutating key residues. We first evaluated wild type Ci-
VSP by using pleckstrin homology (PH) domains fused to green
fluorescent protein (GFP) and testing multiple voltage steps to
map the voltage dependence of each possible Ci-VSP reaction
(Figure 1B). We found evidence supporting the dephosphory-
lation of PI(3,4,5)P3 at the 3-phosphate indicating that Ci-VSP
catalyzes a total of four reactions using three different substrates.
With that new baseline of activity, we probed the contribution
of Y522 and found that both the hydrogen bonding and the
size of Tyr modulate activity. We found the full C2 domain
is necessary for function because the C2 deletion diminished
catalytic activity to control levels. We also found that neutral-
izing a cluster of positive charges on the C2 domain dramat-
ically shifted the voltage dependence of activity suggesting an
interaction with negatively charged lipids. Together our results
support a dual function of the C2 domain in catalysis and
membrane-binding.
Materials and Methods
Molecular Biology
The Ci-VSP in the pSD64TF vector was kindly provided
by Y. Okamura (Osaka University). GFP-PLC-PH was kindly
provided by T. Meyer (Stanford University) and subcloned
into pGEMHE vectors. GFP-TAPP-PH was kindly provided by
T. Balla (NIH) and subcloned into pGEMHE. All mutants were
made using PfuTurbo polymerase (Agilent). All DNA was con-
firmed by DNA sequencing. RNA was transcribed using T7 and
SP6 mMessage mMachine (Ambion) kits.
Voltage Clamp Fluorometry
Voltage clamp fluorometry (VCF) was performed as described
previously (Kohout et al., 2010). Briefly, surgically removed
Xenopus laevis oocytes were injected with 50 nl mRNA at 0.06–
1.8µg µl−1 depending on the experiment. Cells were then incu-
bated in ND-96 (96mM NaCl, 2mM KCl, 1.8mM CaCl2, 1mM
MgCl2, 50mg ml−1 gentamicin, 2.5mM Na pyruvate, and 5mM
HEPES, pH 7.6) at 18◦C for 1–4 days.
A Leica DM IRBE inverted microscope with a Leica HC Pl
APO 20×/0.7 fluorescence objective was used with a Dagan
CA-1B amplifier (Dagan Corporation) and illuminated with a
Lumen Dynamics X-Cite XLED1 light source. Intensity was
measured with a ThorLabs photomultiplier tube. The ampli-
fier and LED were controlled by a Digidata-1440A board
and pClamp10.3 software package (Axon Instruments). For
TMRM experiments, light was filtered through an HQ531/40
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FIGURE 1 | Activity of Ci-VSP in oocytes using PIP sensitive PH
domains. (A) Cartoon of VSP with the VSD, linker, catalytic and C2 domains
labeled. Asterisk depicts location of the TMRM probe (G214C-TMRM).
(B) VSP reactions where the PI(3,4)P2 sensitive GFP-TAPP-PH monitors the
upper reactions (orange) and the PI(4,5)P2 sensitive GFP-PLC-PH monitors
the lower reactions (blue). (C, left) Representative GFP-TAPP-PH traces for
WT∗ Ci-VSP during several voltage steps from a holding potential (hp)
of −100mV and with recovery time between each step. A fluorescence
increase indicates an increase of PI(3,4)P2 on the membrane while a
fluorescence decrease indicates a decrease of PI(3,4)P2 on the membrane;
20mV = red, 70mV = cyan, 140mV = green. The fluorescence may keep
changing even after the end of the voltage step. This is a function of the
affinity of the PH domain and not an indication of voltage independent Ci-VSP
activity. (C, right) 1F/F TAPP fluorescence vs. voltage relationship (FV) with
the fluorescence increase (net 5-phosphatase reaction) predominating at
lower voltages and the fluorescence decrease (net 3-phosphatase reaction)
predominating at higher voltages. Data fit with a double Boltzmann equation.
(D, left) Representative traces of GFP-PLC-PH co-expressed with WT∗
during several voltage steps as in (C). The fluorescence increase indicates an
increase of PI(4,5)P2 on the membrane while the fluorescence decrease
indicates a decrease of PI(4,5)P2 on the membrane; −20mV = purple,
20mV = red, 140mV = green. (D, right) 1F/F PLC FV with the fluorescence
decrease (FV Down, net 5-phosphatase reaction, solid line) and the
fluorescence increase (FV Up, 3-phosphatase reaction, dashed line, inset)
separated. Data fit with a Boltzmann equation. All error bars are ± s.e.m; n ≥
16. Some errors bars are smaller than the size of the symbols.
excitation filter, an HQ593/40 emission filter and a Q562LP
dichroic (Semrock). Fluorescence signals were low-pass fil-
tered at 2 kHz through an eight-pole Bessel filter (Frequency
Devices).
On the day of the experiment, cells were incubated in a high-
potassium solution (92mM KCl, 0.75mM CaCl2, 1mM MgCl2,
10mM HEPES, pH7.5) with 25µM tetramethylrhodamine-6-
maleimide (Invitrogen) for 30min on ice and in the dark. After
extensive washing with ND-96, the cells were stored in ND-
96′ (ND-96 without gentamicin or pyruvate), in the dark and
at 10–19◦C until the time of the experiment. ND-96′ was used
for the recording solution. In all experiments, only cells with
good control of voltage were analyzed. All reported voltages
and voltage steps are actual measurements. For VCF experi-
ments, the voltage protocol consisted of 10mV voltage steps
starting at −150mV and ending at 200mV. The resulting fluo-
rescence was then plotted vs. the voltage to generate the fluores-
cence/voltage relationship (FV).
For experiments with the 5HT2C receptor, an RNA ratio of
40:1 was used for experiments co-expressing Ci-VSP and the
receptor (total RNA ∼0.82µg µl−1). An initial FV protocol (t =
0, voltage steps from −150 to 200mV in 10mV increments)
was followed by perfusion of 10µM serotonin (Sigma) for 5–
10 s while recording the Ca2+-activated chloride channels. The
cell was then perfused with ND-96′ until the final FV protocol at
t = 10min.
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Fluorescent Measurements of Activity
RNA ratios ranging from 2:1 to 60:1µg µl−1 were used for
Ci-VSP and each PH domain (total RNA 0.08–1.43µg µl−1).
Cells were recorded in perfused ND-96′. GFP-PLC-PH and GFP-
TAPP-PH were used to detect PI(4,5)P2 and PI(3,4)P2, respec-
tively, using a GFP filter set (Chroma) consisting of a 470/40
excitation filter, a 525/50 emission filter, and a 495 dichroic. For
the TAPP-PH, 8µM insulin was added to the ND-96′ to promote
PI3K activity and up regulate PI(3,4,5)P3 levels. Ci-VSP expres-
sion levels were confirmed in each oocyte by TMRM labeling
and measurement of the TMRM fluorescence change induced by
VSDmotion. Other conditions were the same as for the VCF. For
PH domain FV experiments, the protocol consisted of voltage
steps from −100mV to +140 or +180mV in irregular incre-
ments. Rest periods of 1.5–5min between voltage steps were used
to allow the cell to recover depleted PIP concentrations before
starting the next voltage step. The resulting fluorescence was then
plotted vs. the voltage to generate the FV relationship.
Data Analysis
Kinetic and steady state fluorescence traces were analyzed using
Clampfit (Molecular Devices), IGOR Pro (WaveMetrics), and
Excel (Microsoft). Steady state voltage-dependent traces were fit
with either single or double Boltzmann equations. TMRM data
was normalized to themaximum amplitude of the Boltzmann fits,
while the PH domain data is shown as 1F/F. Error bars indicate
the standard error of the mean (s.e.m.). Statistical significance
was determined using the Student’s t-test.
Results
Wild Type Activity
To determine VSP activity, we used PH domains that bind spe-
cific PIPs and that are linked to GFP, allowing us to monitor
PIP concentrations by tracking fluorescence on the membrane.
This PH domain assay has been used before to test for Ci-VSP
activity (Halaszovich et al., 2009; Sakata et al., 2011; Kurokawa
et al., 2012; Liu et al., 2012) and has the advantage of being
able to separate out the different possible dephosphorylation
reactions catalyzed by Ci-VSP, unlike channels such as IRK or
KCNQ that are known to only be dependent on PI(4,5)P2 and
thus only test for PI(4,5)P2 concentrations. Using Xenopus laevis
oocytes, we expressed two different GFP-PH domains with Ci-
VSP, the tandem PH domain-containing protein 1 PH domain
(GFP-TAPP-PH) and the phospholipase C PH domain (GFP-
PLC-PH). These two PH domains allow us to monitor both
5- and 3-phosphatase reactions attributed to Ci-VSP because
TAPP-PH binds to PI(3,4)P2 (Kimber et al., 2002; Manna et al.,
2007) while PLC-PH binds to PI(4,5)P2 (Stauffer et al., 1998;
Várnai and Balla, 1998) (Figure 1B). When the 5-phosphate
is removed from PI(3,4,5)P3 leaving PI(3,4)P2 as the product,
GFP-TAPP-PH will go to the membrane, increasing the mem-
brane fluorescence, 1F↑ (Figure 1B). When the 3-phosphate
from PI(3,4)P2 is removed the fluorescence will decrease as
GFP-TAPP-PH comes off themembrane,1F↓ (Figure 1B). GFP-
PLC-PH monitors the second set of reactions by going to the
membrane when the 3-phosphate is removed from PI(3,4,5)P3
leaving PI(4,5)P2 as the product, causing the fluorescence to
increase,1F↑ (Figure 1B). GFP-PLC-PHwill come off the mem-
brane when the 5-phosphate is removed from PI(4,5)P2 leav-
ing PI(4)P, causing a fluorescence decrease, 1F↓ (Figure 1B).
Both reaction pathways end with PI(4)P, however distinguish-
ing the two is important because all three substrates, PI(3,4,5)P3,
PI(3,4)P2, and PI(4,5)P2, are known to regulate different func-
tions in the cell (Balla, 2013).
It is important to note that the reactions observed using
the PH domains are all net reactions. For example, an increase
of GFP-TAPP-PH to the membrane indicates a net increase of
PI(3,4)P2 at the membrane. Other processes within the cell,
including the kinases responsible for phosphorylating PIPs, will
influence the relative concentrations of PIPs during the assay.
These processes obscure the actual kinetics of the reactions due to
Ci-VSP activity. However, no other process influencing the PIP
concentrations in the cell is directly voltage dependent and the
overall concentration of PI(3,4)P2 must increase for GFP-TAPP-
PH to accumulate on the membrane. Therefore, the simplest
interpretation of a voltage-dependent increase of GFP-TAPP-
PH is an indication of Ci-VSP voltage-dependent 5-phoshpatase
activity. At higher voltages, the fluorescence decrease of GFP-
TAPP-PH is likewise a mixture of reactions. Because the decrease
dominates the signal, the simplest interpretation is an increase
in the 3-phosphatase activity of VSP. The same is true for the
GFP-PLC-PH domain assay.
First, we tested the PI(3,4)P2 pathway by co-expressing GFP-
TAPP-PH with Ci-VSP in X. laevis oocytes. To confirm the
expression of Ci-VSP, all proteins presented here have the
G214C mutation in the VSD allowing us to label the VSD
with a fluorophore, tetramethylrhodamine maleimide (TMRM)
(Figure 1A). Thus, wild type Ci-VSP (WT∗) is G214C Ci-VSP
labeled with TMRM. The TMRM fluorescence was used to estab-
lish Ci-VSP expression before testing activity using VCF (data
not shown). To map out the voltage dependence of each possi-
ble dephosphorylation reaction, we first tested WT∗ with a wide
range of voltages, from −100 to +140mV using two-electrode
voltage clamp. At lower voltages, we observed an increase of
GFP-TAPP-PH to the membrane suggesting the expected 5-
phosphatase activity of WT∗ (Figure 1C, left, red).We used short
voltage steps of 10 s to allow for complete recovery of the PIP
concentrations between each voltage step. As a result of the short
steps, the fluorescence may continue to change after the voltage
step has turned off. This is a function of the affinity of the PH
domain and not an indication that VSP is still active. At interme-
diate voltages, both an increase and a decrease in fluorescence
are visible indicating that both 5- and 3-phosphatase activities
are observable (Figure 1C, left, cyan). At higher voltages, a flu-
orescence decrease predominates suggesting the 3-phosphatase
activity of WT∗ (Figure 1C, left, green).
By plotting the fluorescence at the end of each voltage step
vs. the voltage of each step (TAPP FV), we show a clear volt-
age dependence of each reaction (Figure 1C, right). We observed
increasing fluorescence from −100mV until 20mV (called here
TAPP FV Up), indicating more PI(3,4)P2 at the membrane sug-
gesting Ci-VSP 5-phosphatase activity. At 70mV and above, the
majority of the signal is a decrease in fluorescence (called here
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TAPP FV Down), indicating less PI(3,4)P2 at the membrane
suggesting Ci-VSP 3-phosphatase activity (Figure 1C, right).
Between 20 and 70mV, we observe a mixture of increasing and
decreasing fluorescence within the same voltage step indicating
that both 5- and 3-phosphatase reactions can occur at the same
voltage. Using a double Boltzmann equation to fit the FV from
each cell, we were able to separate out the V1/2 for the fluo-
rescence increase from the V1/2 for the fluorescence decrease
(Table 1). Note, the reactions behind the changes in fluorescence
are in equilibrium with each other thus we are measuring the
net PI(3,4)P2 concentration at each voltage. We cannot rule out
simultaneous 5- and 3-phosphatase VSP activity at the lower or
higher voltage.We are limited to interpreting the net fluorescence
change where a decrease suggests the production of PI(3,4)P2
and an increase suggests the dephosphorylation of PI(3,4)P2.
Our double Boltzmann fits indicate a V1/2 for the fluorescence
decrease of 44 ± 3, which is higher than for the fluorescence
increase, 9 ± 5, suggesting that the 3-phosphatase predominates
at higher voltages while the 5-phosphatase reaction predominates
at the lower voltages. Our results agree with previous results indi-
cating that voltage may control the substrate specificity of Ci-VSP
(Kurokawa et al., 2012).
Switching to the PI(4,5)P2 pathway, we co-expressed WT∗
with GFP-PLC-PH and observed a dominant decrease in fluores-
cence starting at lower voltages (Figure 1D, left, purple) indicat-
ing 5-phosphatase activity. A short fluorescence increase clearly
develops at higher voltages (Figure 1D, left, red and green)
though the overall change is still a decrease. This fluorescence
increase suggests PLC is also following two reactions where the
fluorescence increase indicates more PI(4,5)P2 on the membrane
while the fluorescence decrease indicates less PI(4,5)P2 on the
membrane. The fluorescence decrease dominates at all voltages
obscuring the shorter-lived fluorescence increase. To separate
the 5- vs. 3-phosphatase reactions, we plotted the GFP-PLC-PH
fluorescence decrease vs. voltage relationship (PLC FV Down,
Figure 1D, right) separately from the fluorescence increase vs.
voltage relationship (PLC FV Up, Figure 1D, right, inset). We fit
the FVs from individual cells using single Boltzmann equations to
determine the voltage dependence of each reaction. Using these
PLC FVs, we found that the 5-phosphatase activity started at
−20mV with a V1/2 of 37 ± 4 while the 3-phosphatase activity
was not visible until ≥ 20mV with a V1/2 of 70 ± 5 (Figure 1D,
right, Table 1), suggesting Ci-VSP is capable of dephosphorylat-
ing PI(3,4,5)P3 at the 3-phosphate, but it only appears to domi-
nate the reactions under higher voltage conditions. The apparent
dominance of the 3-phosphatase reaction at higher voltages for
two independent reporters suggests that the voltage may control
the specificity of the substrate in agreement with previous studies
(Kurokawa et al., 2012). We next turned to testing the contri-
butions of the C2 domain by comparing C2 mutations to wild
type.
C2 Domain Contribution to Activity Via the Third
Inactivated Calcium-Binding Loop
The contribution of the C2 domain to Ci-VSP activity was first
discovered with the crystal structures, where Y522 on the third
inactivated CBL (iCBL3) of the C2 was found pointing into the
active site (Matsuda et al., 2011; Liu et al., 2012). The Y522 was
mutated to an alanine (Ala) and shown to influence activity by
slowing the rate of PI(3,4)P2 dephosphorylation (Liu et al., 2012).
We applied our wider voltage range PH domain assay to Y522A∗
(G214C Y522A labeled with TMRM) to further probe the role of
this key residue. We observe both 5- and 3-phosphatase activities
for Y522A∗, though the equilibrium of net reactions are altered
(Figure 2).WhenGFP-TAPP-PHwas co-expressed with Y522A∗,
a representative 70mV step shows a mixture of increasing and
decreasing fluorescence suggesting both 5- and 3-phosphatase
activities (Figure 2A, left, magenta) as compared to WT∗ that
shows a predominant decrease (Figure 2A, left, black). Plotting
the TAPP FV shows that at higher voltages, the fluorescence
decrease of Y522A∗ became even more pronounced, indicating
that Y522A∗ still enters a dominant 3-phosphatase activity state
(Figure 2A, right, magenta). As seen before (Liu et al., 2012),
Y522A∗ produced a larger amplitude increase in fluorescence at
TABLE 1 | Voltage dependence of activity.
VSP TAPP FV fits PLC FV fits
n V1/2 up V1/2 down n V1/2 down V1/2 up
WT* 24 9±5 44± 3 16 37±4 70± 5
Y522A* 8 18±6 51± 4 7 47±4 87± 6*
Y522F* 8 27±5* 58± 4** 6 58±5* 94± 6**
CS* 18 60±1 n/a 16 n/a@ n/a
1C2* 9 64±5# n/a 9 n/a@ n/a
QuadK* 6 50±9* 99± 5*** 7 68±4*** 115± 5***
K553Q* 6 32±2*** 53± 2* 6 49±7 79± 7
K554Q* 6 14±6 52± 8 7 37±4 63± 3
K555Q* 6 38±9* 72± 8* 6 58±12 89± 13
K558Q* 6 15±3 39± 3 6 40±6 77± 5
Average V1/2 from double Boltzmann fits to each cell (n) for the TAPP FVs and single Boltzmann fits for the PLC FVs. Student t-tests,
∗p ≤ 0.05; ∗∗p ≤ 0.01; ∗∗∗p ≤ 0.001 (compared
to WT∗). #Not significant (compared to CS∗); n/a, no data to fit; n/a@, amplitude too small to fit.
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FIGURE 2 | Third inactivated calcium-binding loop from C2 domain
shifts voltage dependence of VSP activity. (A, left) Representative
GFP-TAPP-PH trace during a step from an hp of −100mV to +70mV
for WT∗ (black), Y522A∗ (magenta) and Y522F∗ (green). Both Y522A∗
and Y522F∗ show a similar fluorescence increase and decrease during
the course of the voltage step indicating both PI(3,4)P2 production and
depletion while WT∗ shows mainly a fluorescence decrease at this
voltage, indicating PI(3,4)P2 depletion. TAPP-PH reaction listed on top.
(A, right) 1F/F TAPP FV. Both Y522A∗ and Y522F∗ show pronounced
fluorescence decreases at higher voltages, indicating both cause
PI(3,4)P2 depletion at higher voltages. Y522F
∗ shifted the voltage
dependence of activity by 14–18mV (Table 1) and Y522A∗ increased
the peak amplitude of the response (Student t-test, ∗p ≤ 0.05),
suggesting the importance of both the size and hydrogen bonding of
position 522, n ≥ 8. Data fit with a double Boltzmann. (B, left) 1F/F
PLC FV Down. The fluorescence decrease FV (net 5-phosphatase
activity) from GFP-PLC-PH fit with a Boltzmann. Inset shows 40mV
step representative traces. Scale bars for inset are 5% 1F/F and 2 s.
Colors as in (A). Y522F∗ shifted the voltage dependence by 21mV
(Table 1). PLC-PH reaction listed on top. (B, right) 1F/F PLC FV Up.
The fluorescence increase FV (net 3-phosphatase activity) from the
same GFP-PLC-PH data as in (B, left), fit with a Boltzmann. Inset
shows enlarged 40mV step representative traces (same as in B, left).
Scale bars for inset are 1% 1F/F and 0.2 s. Both Y522A∗ and Y522F∗
show statistically significant voltage-dependent shifts of activity to higher
voltages (Table 1), n ≥ 6 (C, left) Representative TMRM fluorescence
trace during a step from an hp of −80 to +200mV for WT∗ and
Y522F∗. Colors as in (A). Traces are normalized to the maximal
fluorescence change. The voltage trace reports the actual voltage
recorded during acquisition. Y522F∗ causes a small deceleration of the
VSD activation relative to WT∗. (C, right) Normalized TMRM FV. Data fit
to single Boltzmann equation and normalized to the fit. Y522F∗ shifted
the voltage dependence of the VSD motions by over 20mV, n ≥ 10,
WT∗ V1/2 = 55.1 ± 0.4, slope = 23.9 ± 0.4; Y522F
∗ V1/2 = 77.8 ±
0.6, slope = 26.8 ± 0.5. All error bars are ± s.e.m. Some errors bars
are smaller than the size of the symbols.
20mV indicating higher PI(3,4)P2 concentrations on the mem-
brane compared to WT∗ (statistically significant, Student’s t-test,
p ≤ 0.05). The broader voltage range used here shows that the
increase is maintained even at higher voltages suggesting that the
slower PI(3,4)P2 dephosphorylation is consistent across voltages.
When fitting the FVs to a double Boltzmann, the V1/2 values
were not statistically different between WT∗ and Y522A∗ indi-
cating the voltage dependence of the reactions was not altered
(Table 1) even when the relative rates between the reactions
were different. The mechanism behind Y522 is still unknown
so we repeated our experiments with a phenylalanine mutation
to retain the size of the ring, but remove the hydrogen bond-
ing capability. Interestingly, the Y522F∗ (G214C Y522F labeled
with TMRM) activity does not show the same larger amplitude
signal above WT∗ levels suggesting the rates are the same, how-
ever Y522F∗ clearly shifted the voltage dependence by almost
20mV (Figure 2A, right, green, Table 1) suggesting that hydro-
gen bonding may be a factor for Y522 influence on the volt-
age dependence of catalysis independent of the size of the side
chain.
Frontiers in Pharmacology | www.frontiersin.org 6 April 2015 | Volume 6 | Article 63
Castle et al. VSP C2 domain dual function
When testing the PI(4,5)P2 pathway using GFP-PLC-PH,
we observed a different trend with Y522A∗. The amplitudes
of Y522A∗ were not significantly different in the fluorescence
decrease nor in the increase consistent with previous studies (Liu
et al., 2012). Fitting the PLC FVDown revealed no significant dif-
ference between the voltage dependence of Y522A∗ compared to
WT∗ (Figure 2B, left). The PLC FV Up did reveal a small differ-
ence between Y522A∗ and WT∗ with the V1/2 shifted by 17mV
when the data were fit with a single Boltzmann (Figure 2B, right,
Table 1). Y522F∗, on the other hand, shifted both the PLC FV
Down and Up to higher voltages by 20mV (Figure 2B, Table 1)
suggesting both 3- and 5-phosphatase activities were changed.
Overall, Y522A∗ changed the activity of VSP in two ways, by
changing the reaction rates of the PI(3,4)P2 pathway while shift-
ing the 3-phosphatase reaction of the PI(4,5)P2 pathway to higher
energy suggesting that the Y522 position plays a role in the sub-
strate selectivity of VSP. Y522F∗ had a stronger influence on
activity even though it is themore conservativemutation, shifting
the voltage dependence of both reaction pathways suggesting that
the hydrogen bonding capability of the Y522 position strongly
influences the voltage dependence of activity.
We also tested how these mutations altered another aspect
of VSP function, the motions of the VSD. The G214C label-
ing site has been well-established to monitor the motions of
the VSP S4 helix by labeling with TMRM and observing the
changes in TMRM fluorescence using VCF (Kohout et al.,
2008; Villalba-Galea et al., 2008). Interestingly, while Y522A∗
accelerated the VSD activation and deactivation kinetics (Liu
et al., 2012), Y522F∗ had only a minor effect on the activa-
tion kinetics (Figure 2C, left). Y522F∗ significantly shifted the
voltage dependence of those motions (Figure 2C, right) suggest-
ing that maintaining the size of the side chain and only changing
the hydrogen bonding capability influences the voltage depen-
dence of VSP function more than removing both the size and
the hydrogen bonding. The PH domain assay combined with the
TMRM VCF data strongly suggest other factors may be involved
in the mechanism of action for Y522.
Deleting the C2 Domain Eliminates Activity
It is possible that the C2 domain may modulate activity while
not being necessary for activity. To address this, we deleted
the entire C2 domain (1C2∗, G214C deleted C2 labeled with
TMRM), truncating the protein at amino acid 432 and tested
both PI(3,4)P2 and PI(4,5)P2 reaction pathways. Starting with
the PI(3,4)P2 pathway, we co-expressed GFP-TAPP-PH with
1C2∗ and observed a robust rise in fluorescence at +140mV
(Figure 3A, left, red). That rise was similar to the fluorescence
increase of a catalytically dead Ci-VSP, C363S (CS∗, G214C
C363S labeled with TMRM) used as a control (Figure 3A, left,
cyan). This is because X. laevis oocytes express two endogenous
VSPs, Xl-VSP 1 and 2 (Ratzan et al., 2011; Liu et al., 2012).
Both 1C2∗ and CS∗ were distinct from WT∗ where the fluores-
cence predominantly decreases at that voltage (Figure 3A, left,
black). Over the full range of voltages, 1C2∗ induced only flu-
orescence increases similar to those seen for CS∗ with the same
voltage dependence (Figure 3A, right, Table 1). Interestingly,
some 1C2∗ cells gave slightly higher magnitude changes in
fluorescence which might imply a small degree of activity above
control. However, those differences were never statistically dif-
ferent from CS∗ (Figure 3A, right), indicating 1C2∗ is not
functional.
We observed similar results for the PI(4,5)P2 pathway tested
with GFP-PLC-PH. 1C2∗ caused a small fluorescence decrease
during the+140mV step, similar to that of CS∗ and in sharp con-
trast to the dramatic decrease of WT∗ (Figure 3B, left). No fluo-
rescence increase was ever observed for1C2∗, also similar to CS∗
control (Figure 3B, left). The PLC FV Down also shows a slightly
larger magnitude change in the fluorescence for 1C2∗ over the
larger voltages, however, they are not statistically different from
CS∗ (Figure 3B, right), indicating that 1C2∗ is no longer active
against any of its substrates. The signals for both CS∗ and 1C2∗
with GFP-PLC-PH were very small, often < 1% 1F/F, making
fitting that data unreasonable. As with the other mutants, we con-
firmed the expression of 1C2∗ using TMRM and VCF. 1C2∗
still expressed, indicating the lack of activity is not due to lack
of protein and VCF results showed similar VSD activation kinet-
ics, while the VSD deactivation kinetics were slower (Figure 3C,
left). The voltage dependence of1C2∗ VSDmotions were slightly
shifted to V1/2 = 41±1 as compared toWT∗, V1/2 = 55.1±0.3.
This shift can be partly attributed to a change in the slope (1C2∗
slope = 29 ± 1; WT∗ slope = 23.9 ± 0.4) suggesting the volt-
age dependence is not as pronounced (Figure 3C, right). Though
less energy is needed to move the VSD, it takes longer for the
VSD to recover to a resting state when the C2 domain has been
deleted. These changes in kinetics and voltage dependence show
that the C2 domain influences the overall function of VSP, both
the motions of the VSD as well as catalysis.
C2 Domain Positive Charge Cluster Influences
VSP Activity
While the VSP C2 contribution to catalysis is unique, the long
established role of C2 domains is to bind lipids (Nalefski and
Falke, 1996; Lemmon, 2008) even when calcium is not involved
as in the case of protein kinase C ε (PKCε) and PTENC2 domains
(Corbalán-García et al., 2003; Sánchez-Bautista et al., 2007). Sim-
ulation data suggests that a cluster of positive charges on the
VSP C2 could be contributing to binding PI(4,5)P2 lipids (Kalli
et al., 2014). Four of these positive charges are found in the fourth
CBL (Figure 4A). To test whether these positive charges play a
role in VSP function, we mutated all four lysines (Lys), K553,
K554, K555, and K558, to glutamine (Gln) (quadK∗, G214C
K553-5Q K558Q labeled with TMRM), neutralizing all four
positive charges simultaneously. When tested with GFP-TAPP-
PH, we observed a significant shift in the voltage-dependent
activity; at +70mV, quadK∗ still displayed a strong fluores-
cence increase in contrast to the clear fluorescence decrease
displayed by WT∗ (Figure 4B, left). QuadK∗ was still capable
of inducing a fluorescence decrease in response to a voltage
pulse, but required >100mV before it dominated the net reac-
tions (Figure 4B, right). Overall, the activity of quadK∗ required
higher energy with both TAPP FV Up and Down shifted to
higher voltages by ≥40mV (Table 1). The 5-phosphatase reac-
tion had similar amplitudes between WT∗ and quadK∗, but the
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FIGURE 3 | C2 domain required for VSP activity. (A, left) Representative
GFP-TAPP-PH trace during a single voltage step from an hp of −100mV to
+140mV for WT∗ (black), 1C2∗ (red), and CS∗ (cyan). 1C2∗ shows minimal
activity above endogenous levels (CS∗). TAPP-PH reaction listed on top. (A,
right) 1F/F TAPP FV. 1C2∗ activity not significantly different from CS∗
indicating only endogenous activity even at the highest voltage recorded,
n ≥ 9. Data fit with a single Boltzmann. (B, left) Representative GFP-PLC-PH
co-expressed with WT∗, 1C2∗, and CS∗ during a +140mV step. WT∗ shows
the characteristic increase and decrease in fluorescence indicating both
PI(4,5)P2 production and depletion while 1C2
∗ and CS∗ show almost no
change in fluorescence. PLC-PH reaction listed on top. (B, right) 1F/F PLC
FV Down (net 5-phosphatase reaction). 1C2∗ shows no activity (either 3- or
5-phosphatase) beyond that of endogenous VSPs in the oocytes. Colors as in
(A), n ≥ 9. (C, left) Representative TMRM fluorescence trace during a step
from a hp = −80 to +200mV for WT∗ and 1C2∗. Traces are normalized to
the maximal fluorescence change. The voltage trace reports the actual
voltage recorded during acquisition. 1C2∗ has similar VSD activation kinetics
to WT∗ but slower deactivation kinetics. (C, right) Normalized TMRM FV. Data
fit to single Boltzmann equations and normalized to the fit. The 1C2∗ voltage
dependence is shifted to lower voltages. WT∗ V1/2 = 55.1 ± 0.4, slope =
23.9 ± 0.4; 1C2∗ V1/2 = 41± 1, slope = 29 ± 1. Error bars are ± s.e.m.,
n ≥ 11. Some errors bars are smaller than the size of the symbols.
3-phosphatase reaction showed a smaller amplitude change sug-
gesting that some reaction rates may be altered in quadK∗. We
found similar results when testing the PI(4,5)P2 pathway with
GFP-PLC-PH. At a representative 40mV, quadK∗ shows a signifi-
cantly smaller fluorescence decrease and no fluorescence increase
compared to WT∗ (Figure 4C, left). However, at larger volt-
ages, both reactions are clearly visible, though shifted by≥30mV
(Figure 4C, right, Table 1). The overall amplitude of the GFP-
PLC-PH fluorescence was larger for quadK∗ when monitoring
the fluorescence decrease and smaller when monitoring the flu-
orescence increase (Figure 4C, right) supporting the hypothesis
that quadK∗ has also shifted the relative reaction rates of VSP.
Using VCF, we observed that the quadK∗ had only minor effects
on the deactivation kinetics (Figure 4D, left), while the voltage
dependence of the VSD motions were shifted by >10mV to
higher voltages (Figure 4D, right). These lysines are not likely
to interact with the bound substrate as seen by the crystal struc-
ture (Liu et al., 2012). Instead they may be modulating the volt-
age dependence of voltage sensor movements and activity either
by allosteric effects or by changing the face of the protein that
interacts with the membrane.
To further dissect the contributions of these lysines, we indi-
vidually mutated them to Gln. The alignment shows that K553
and K555 are the most well-conserved across several VSP species,
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FIGURE 4 | C2 domain positive charge cluster significantly shifts
voltage-dependent activity. (A, left) Alignment of the fourth inactivated CBL
from several species of VSP. Quadruple Lys mutant, quadK∗, positions
highlighted by asterisks. Conserved Lys shown in yellow. (B, left)
Representative GFP-TAPP-PH trace during a step from an hp of −100mV to
+70mV for WT∗ (black) and quadK∗ (purple). QuadK∗ shows significant levels
of PI(3,4)P2 production while WT
∗ shows predominantly PI(3,4)P2 depletion
during a 70mV step. TAPP-PH reaction listed on top. (B, right) 1F/F TAPP FV.
QuadK∗ significantly shifts the PI(3,4)P2 production and depletions to higher
voltages (>40mV, Table 1), n ≥ 6. Data fit with a double Boltzmann. (C, left)
Representative GFP-PLC-PH trace during a step from an hp of −100mV to
+40mV for WT∗ and quadK, colors as in (B). QuadK∗ again shows a different
level of PI(4,5)P2 production as compared to wild type. PLC-PH reaction
listed on top. (C, right) 1F/F PLC FV with the fluorescence decrease (Down,
net 5-phosphatase reaction) in solid lines and the fluorescence increase
shown in inset with dashed lines (Up, net 3-phosphatase reaction). QuadK∗
significantly shifted the PI(4,5)P2 production and depletion to higher voltages
(>30mV, Table 1), n ≥ 7. Data fit with a Boltzman. (D, left) Representative
TMRM fluorescence trace during a step from an hp of −80 to +200mV for
WT∗ and quadK∗. Colors as in (B). Traces are normalized to the maximal
fluorescence change. The voltage trace reports the actual voltage recorded
during acquisition. QuadK* does not significantly influence the VSD activation
kinetics while slowing the deactivation kinetics modestly. (D, right) Normalized
TMRM FV. A small (12mV) shift in the voltage dependence of VSD motions
with quadK∗. Data fit to single Boltzmann equations and normalized to the fit,
n ≥ 10, WT∗ V1/2 = 55.1 ± 0.4, slope = 23.9 ± 0.4; quadK
∗ V1/2 = 67.6 ±
0.7, slope = 27.4 ± 0.6. All error bars are ± s.e.m. Some errors bars are
smaller than the size of the symbols.
K558 is somewhat conserved while K554 is not conserved at all
(Figure 4A). We co-expressed the individual Lys to Gln muta-
tions with either GFP-TAPP-PH (Figure 5A) or GFP-PLC-PH
(Figure 5B) to determine their activities relative to WT∗ and
quadK∗. For GFP-TAPP-PH, the individual mutants K553Q∗ and
K555Q∗ show a different amplitude change in the fluorescence
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FIGURE 5 | Individual mutations in the C2 positive charge cluster shift
some, not all activity. (A, left) Representative GFP-TAPP-PH trace during a
step from an hp of −100mV to 0mV for WT∗ (black), K553Q∗ (rust), K554Q∗
(orange), K555Q∗ (blue), and K558Q∗ (green). Both K553Q∗ and K555Q∗
show a smaller change in fluorescence compared to WT∗, K554Q∗, and
K558Q∗, indicating less PI(3,4)P2 production at 0mV. TAPP-PH reaction
listed on top. (A, right) 1F/F TAPP FV. Both K553Q∗ and K555Q∗ show
significant shifts in the voltage dependence of activity (10–30mV) and their
sum recapitulates the net 5-phosphtase shift from quadK∗, but not the net
3-phosphatase shift (gray line shows quadK∗), n ≥ 6. Data fit with a double
Boltzmann. (B, left) 1F/F PLC FV Down (net 5-phosphatase activity) from
GFP-PLC-PH co-expressed with individual Lys to Gln mutations, fit with a
single Boltzmann. Any shift in the voltage dependence is not significant
(Table 1). Colors as in (A), n ≥ 6. PLC-PH reaction listed on top. (B, right)
1F/F PLC FV Up (net 3-phosphatase activity) from the same GFP-PLC-PH
data as in (B, left), fit with a single Boltzmann. Again, none of the V1/2 shifts
are significant (Table 1), n ≥ 6. (C, left) Representative TMRM fluorescence
trace during a step from an hp of -80 to +200mV for WT∗, K553Q∗,
K554Q∗, K555Q∗, and K558Q∗. Colors are as in (A). Traces are normalized
to the maximal fluorescence change. The voltage trace reports the actual
voltage recorded during acquisition. K553Q∗ and K555Q∗ slightly slow down
the activation and deactivation kinetics of the VSD motions. (C, right)
Normalized TMRM FV. All Lys to Gln mutations shifted the VSD motions by
6–17mV to higher voltages. Data fit to single Boltzmann equations and
normalized to the fit, n ≥ 9. WT∗ V1/2 = 55.1 ± 0.4, slope = 23.9 ± 0.4;
K553Q∗ V1/2 = 68 ± 1, slope = 32 ± 1; K554Q
∗ V1/2 = 71.8 ± 0.8, slope
= 26.6 ± 0.7; K555Q∗ V1/2 = 67.3 ± 0.9, slope = 30.8 ± 0.9; K558Q
∗
V1/2 = 61.3 ± 0.9, slope = 28.7 ± 0.9. All error bars are ± s.e.m.
for a representative 0mV step, compared to WT∗, K554Q∗, and
K558Q∗ (Figure 5A, left). This segregation continues in the full
FVs, where K553Q∗ and K555Q∗ each show a shift in the flu-
orescence to higher voltages for the TAPP FV Up and Down
while K554Q∗ and K558Q∗ are not statistically different from
WT∗ in either direction (Figure 5A, right, Table 1). The sum
of the FV shift for K553Q∗ and K555Q∗ equals the shift for
quadK∗ when looking at the TAPP FV Up reaction but not for
the TAPP FV Down reaction (Figure 5A, right, Table 1). For
co-expression with GFP-PLC-PH, we observe a different trend
where the minor changes observed in the PLC FV Down and Up
for the individual mutations were not statistically different com-
pared to WT∗ (Figure 5B, Table 1). The sum of the amplitude
from each individual Lys to Gln mutant also did not recapitu-
late the amplitude changes seen with quadK∗ for the PI(4,5)P2
pathway. Both the TAPP and PLC data indicate that the quadK∗
shift may bemore than just the sum of the individual Lys mutants
and implies other factors may contribute. The VSDmotionsmea-
sured by VCF were only slightly altered (Figure 5C, left) while
all the TMRM FVs were shifted to higher voltages by 6–17mV
(Figure 5C, right). The TMRM data for the individual Lys to Gln
mutations again does not recapitulate the quadK∗ TMRM data
since K553Q∗, K554Q∗, and K555Q∗ all shift the TMRM FV by
almost the same amount as quadK∗ (V1/2’s are not statistically
different between quadK∗ andK553-5Q∗). The TMRMdata com-
bined with the PH domain data indicates that the shift seen from
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quadK∗ is not the simple sum of the individual Lys positions
and other factors are influencing VSP through those positive
charges.
Lipid Contribution to C2 Domain Function
To probe whether the activity shifts seen with the Lys mutants
stem from an interaction with the membrane through PIPs, we
co-expressed quadK∗ with the serotonin 2C receptor (5HT2C).
The 5HT2C G protein coupled receptor activates endogenous
phospholipase C (PLC), leading to the cleavage of the PI(4,5)P2
phosphodiester bond creating diacylglycerol (DAG) and inositol-
(1,4,5)-trisphosphate (IP3), effectively removing PI(4,5)P2 from
the membrane (Julius et al., 1988). Previous results have shown
that Ci-VSP VSD motions are dependent on PI(4,5)P2 in the
membrane using the 5HT2C receptor (Kohout et al., 2010).
Here we used the same background mutation, D331A, as in
the previous study (Kohout et al., 2010) because it inactivates
VSP catalysis simplifying the interpretation of results by remov-
ing VSP-induced PIP depletion. After Ci-VSP co-expression
with 5HT2C, the TMRM FV is recorded before the addition
of the serotonin, under native PI(4,5)P2 concentration. Then,
in the same cell, the addition of 10µM serotonin depletes the
PI(4,5)P2 and after 10min, we re-measure the FV. We confirmed
the activation of the PLC pathway by recording the calcium-
activated chloride channels that are natively expressed in oocytes
(Figure 6A). These channels open as a result of the IP3-induced
calcium release from the internal stores of the cell. We repeated
the previously published results using DA∗ (G214C D331A
labeled with TMRM) and found a robust shift in the TMRM FV
after addition of serotonin and PI(4,5)P2 depletion (Figure 6B).
We conducted the same experiment with DA/quadK∗ (G214C
D331A quadK labeled with TMRM) and found that the FV still
shifts after depletion of PI(45)P2 in the membrane (Figure 6C)
indicating that those positive charges are not contributing to
the PI(4,5)P2-induced voltage-dependent VSD rearrangements.
If these C2 Lys residues interact with the membrane, it maybe
be through a combination of negatively charged lipids instead of
exclusive interactions with PI(4,5)P2.
FIGURE 6 | PI(4,5)P2 depletion does not alter voltage dependence of
VSD motions. (A) Current trace showing the activation of the endogenous
Ca2+-activated chloride channel following addition of serotonin in oocytes
expressing the 5HT2C receptor and Ci-VSP. 5HT2C receptor activation of
the oocyte PLC pathway results in the conversion of PI(4,5)P2 into IP3 and
DAG. The IP3 causes an increase in intracellular Ca
2+ leading to the
activation of the chloride channel. hp = −80mV. (B,C) TMRM FVs before
(black) and 10min after (magenta) application of 10µM serotonin. Activation
of PLC through the 5HT2C receptor leads to depletion of PI(4,5)P2 in the
membrane and results in a shift in the DA∗ (B) and DA/quadK∗ (C) TMRM
FVs after addition of serotonin. In both cases, the VSD motions are sensitive
to the PI(4,5)P2 in the membrane, indicating that the DA/quadK
∗ may not
depend on PI(4,5)P2 in the membrane to cause the activity shifts seen in
Figure 4. DA∗ (no serotonin) V1/2 = 21.8 ± 0.3, slope = 19.9 ± 0.2; DA
∗
(serotonin) V1/2 = 31.7 ± 0.6, slope = 26.2 ± 0.5; DA/quadK
∗ (no serotonin)
V1/2 = 48.3 ± 0.2, slope = 20.7 ± 0.2; DA/quadK
∗ (serotonin) V1/2 = 54.0
± 0.6, slope = 25.0 ± 0.5. All error bars are ± s.e.m. (D) Representative
TMRM fluorescence traces during a step from an hp of −80 to +200mV for
WT∗ (black), DA∗(gray), and DA/quadK∗ (purple). Traces are normalized to
the maximal fluorescence change. DA∗ significantly slows down the
repolarization kinetics while DA/quadK∗ kinetics were faster. (E)
Representative TMRM fluorescence traces during a step from an hp of −80
to +200mV for DA∗ (black), DA/K553Q∗ (rust), DA/K554Q∗ (orange),
DA/K555Q∗ (blue), and DA/K558Q∗ (green). Traces are normalized to the
maximal fluorescence change. The voltage trace reports the actual voltage
recorded during acquisition. Inset shows full acquisition with the fluorescence
returning to baseline. Scale bar for inset is 100ms. All Lys to Gln mutations in
the D331A background maintained the slow or slower kinetics from DA∗
alone. The individual mutations do not sum to equal the effect observed for
DA/quadK∗ in (D).
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Interestingly, the DA/quadK∗ disrupted the characteristic
slower repolarization kinetics for DA∗, making them faster
(Figure 6D). The individual Lys to Gln, on the other hand, gave
the same slow kinetics or even slower kinetics than DA∗ alone
(Figure 6E). The influence of the DA/quadK∗ on VSD kinetics,
but not of the individual mutations, further supports the idea that
the effects from quadK∗ are more than the sum of the individual
mutations and other factors are influencing the motions. Fur-
ther experiments are needed to fully explore potential membrane
interactions with these residues.
Discussion
We have probed the contributions of the VSP C2 domain by
testing catalysis, motions of the VSD, and the influence of the
membrane. We have found that the VSP C2 has a strong influ-
ence on activity through both direct and indirect contributions
to the active site. The indirect influence may be allosteric or may
be through interactions with the membrane. In the past, much of
the field has concentrated on understanding how the VSD or how
the linker works in VSP. Through our findings, the C2 domain
has emerged as a critical factor for understanding both catalysis
and membrane interactions of VSP.
When testing for activity, we used the PH domain system for
detectingmembrane levels of PIPs. The assay allows us to observe
changing PIP concentrations by monitoring the movement of
the PH domain to and from the membrane. The changing flu-
orescence can be attributed to the appropriate voltage-dependent
Ci-VSP activity, either 3- or the 5-phosphatase. This interpre-
tation does not preclude other complicating factors including
the possibility that the changing PIP concentrations themselves
are influencing the reactions or the contributions of the native
kinases and phosphatases within the cell. By testing a broad range
of voltages we were able to observe the fluorescence increases
and decreases of each reporter, determine the voltage depen-
dence of those changes and attribute them to either the 5- or
3-phosphatase activity of Ci-VSP. By doing so, we observed
the disputed 3-phosphate dephosphorylation of PI(3,4,5)P3 in a
voltage-dependent manner. Our results provide evidence for Ci-
VSP 3-phosphatase activity against two substrates, PI(3,4)P2 in
agreement with previous reports (Kurokawa et al., 2012; Liu et al.,
2012) and PI(3,4,5)P3, which has not been clearly shown before.
Thus, wild type Ci-VSP is capable of dephosphorylating three dif-
ferent substrates, PI(3,4,5)P3, PI(4,5)P2, and PI(3,4)P2 via four
different reactions (Figure 1B). Studies in HEK293 cells have
not observed the 3-phosphatase reaction which perhaps indi-
cates a different environment between HEK293 cells and X. laevis
oocytes (Halaszovich et al., 2009). It is important to note that
other studies using GFP-PLC-PH in oocytes have not observed
the fluorescence rise indicating 3-phosphatase activity against
PI(3,4,5)P3 (Kurokawa et al., 2012). This may be due to a func-
tional limitation of the 3-phosphatase activity. We only observed
it at higher voltages (≥40mV) and it may easily get masked by
the strong fluorescence decrease from the 5-phosphatase activity.
All the crystal structures solved to date place the Y522 residue
in the active site (Matsuda et al., 2011; Liu et al., 2012). By
mutating Y522 to either an Ala or a Phe, we were able to probe
what factors are involved in the Y522 contribution to cataly-
sis. We found that both size and hydrogen bonding may play
a role. Unexpectedly, Y522F∗ shifted the voltage dependence of
activity and VSD motions more than Y522A∗ indicating that by
removing the OH alone, higher voltages are needed to achieve the
same level of function, but by removing both the phenyl ring and
the OH group, the voltages were closer to wild type. The crys-
tal structure active site shows a histidine residue, H332, within 4
Å of Y522. It is possible that by removing the hydrogen bond-
ing, Y522F is more likely to form a pi-cation or a pi-pi interaction
between the Y522F and H332. This interaction would need to
be broken for catalysis to progress, thus leading to a larger shift
where higher voltage is necessary to achieve the same level of
function, either catalysis or VSD motions. The native Tyr would
have electron density pulled away from the aromatic ring toward
the active site and the Ala would not contribute to any interaction
and thus would not require the extra energy of activation. Further
experiments will be needed to probe this hypothesis.
Previous results using a 20mV voltage pulse showed that
Y522A decreased the reaction rate for the 3-phosphate dephos-
phorylation of PI(3,4)P2 resulting in increased accumulation
of PI(3,4)P2 on the membrane over wild type (Liu et al.,
2012). We see that same effect over a broad range of voltages,
from 20 to 70mV, for Y522A∗ but not for Y522F∗ suggesting
that the size of the amino acid at position 522 influences 3-
phosphatase activity rate while the hydrogen bonding alone does
not. At ≥70mV, a net fluorescence decrease predominates sug-
gesting 3-phosphatase activity for both mutations indicating that
even with slower reaction rates, the 3-phosphatase reaction is
still capable of dominating. Y522 is conserved across all VSPs
with C2 domains and our results suggest the 522 position func-
tions as a tuner for the reaction rates instead of an absolute
regulator.
While it is clear that Y522 has defined a new role for C2
domains in catalysis, whether the C2 domain was required for
activity was still in question. We deleted the entire C2 domain
starting at amino acid 432 and found that it does not show
any statistically significant activity above the endogenous lev-
els of the Xl-VSP1 and 2. Interestingly, there were a few cells
for both GFP-TAPP-PH and GFP-PLC-PH that showed greater
than endogenous levels of activity suggesting a very low level
of activity. However, with a larger sample size, the resulting
1F/Fs were no longer significant. There may be very low lev-
els of activity that are hard to distinguish from endogenous.
1C2∗ also influenced the voltage-dependent motions of the VSD,
slowing down the repolarization kinetics while shifting the volt-
age dependence to lower voltages. While the majority of VSPs
have C2 domains, a recent report discovered that the salaman-
der VSP (Hynobius nebulosus, Hn-VSP) has a truncated C2 stop-
ping at CBL2 (Mutua et al., 2014). They found no activity for
Hn-VSP using GIRK channels and when they truncated Ci-VSP
at the same position, they also inactivated Ci-VSP. Our results
combined with those from Mutua et al. strongly suggest that
the C2 domain plays an active and necessary role within VSP
function.
An important aspect of C2 domains is their ability to bind
membranes. Modeling studies have suggested that the C2 domain
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from VSP is no different and identified a cluster of Lys residues
that may be involved in interacting with the negatively charged
lipid PI(4,5)P2 (Kalli et al., 2014). We mutated four of those Lys
residues simultaneously to determine whether any functions of
VSP, either activity or the motions of the VSD, were altered as
a result. We found a significant shift (30–40mV) in the voltage
dependence of activity for both 5- and 3-phosphatase reactions as
monitored by both GFP-TAPP-PH and GFP-PLC-PH. The crys-
tal structures illustrate that the shift cannot be a result of a direct
interaction with the bound substrate, thus the effect must be indi-
rect (Matsuda et al., 2011; Liu et al., 2012). The VSD motions
were also altered, with a shift to higher energy in the voltage
dependence of the motions. We mutated the four Lys residues
individually to further dissect the effect and found while some
shifted the activity to higher energy, others did not. The shifts
were not consistent between the GFP-TAPP-PH and GFP-PLC-
PH experiments and of those that did shift, they did not fully
recapitulate the large shift from the quadK∗. The VSD motions
also did not recapitulate the quadK∗ shift where some individ-
ual mutants shifted as far as the quadK∗. Together, these results
indicate that the individual Lys mutants are behaving differently
than when they are all mutated together suggesting a synergistic
effect between the four. This synergistic effect may be allosteric in
nature or due to another player, the membrane.
To address whether the membrane may be interacting with
this positive cluster, we used the serotonin receptor to deplete
membrane PI(4,5)P2 concentrations, the lipid that has been sug-
gested to interact with this region (Kalli et al., 2014). Previ-
ous results have shown that the VSD motions are sensitive to
PI(4,5)P2 concentrations, so we used the sameVCF assay tomon-
itor the voltage-dependent motions of the VSD before and after
PI(4,5)P2 depletion. DA/quadK∗ still shifted the voltage depen-
dence of the VSDmotions even after PI(4,5)P2 depletion suggest-
ing those Lys residues are not involved in the shift. These results
do not negate the C2 interaction with the membrane however.
One possibility is an interaction with negatively-charged phos-
phatidylserine, which has been shown to interact with the PTEN
C2 domain (Shenoy et al., 2012a,b; Nanda et al., 2014). Other neg-
atively charged lipids such as other VSP substrates, PI(3,4,5)P3
and PI(3,4)P2, may also be involved. Other lipids are not tested
here since the 5HT2C receptor activates PLC specifically tar-
geting PI(4,5)P2 and not other lipids. Further experiments are
needed to determine the membrane-binding contribution of the
VSP C2 domain.
While it is clear from our studies that Y522 and the polyly-
sine cluster play a significant role in VSP function, the mutations
tested here do not recapitulate the loss of function seen when the
entire C2 domain is deleted. Other aspects of the VSP C2 may
contribute to VSP catalysis and lipid-binding while other roles
for the C2 may also exist that have not been tested, such as lipid
shuttling to the active site or protein–protein interactions. Other
C2 domains have been shown to mediate protein–protein inter-
actions, such as the synaptic RIM (Rab3-interacting molecule).
This protein has two C2s that fold in the canonical β-sandwich,
however disease mutations are found on the bottom face of the
protein, away from the CBLs and structural studies suggest that
the protein-binding region is Ca2+-independent and mediated
by the bottom face (Dai et al., 2005). The PKCε C2 has also been
shown to function as a protein interaction domain (Johnson et al.,
1996; Schechtman et al., 2004). Thus, further experiments are
needed to fully understand how the C2 domain is contributing
to VSP function.
FIGURE 7 | Model of the C2 domain interaction with the membrane
and influence in a feedback mechanism. At resting membrane
potentials, the phosphatase domain is on the membrane but inactive. At
activating membrane potentials, the VSD changes the conformation of
the linker allowing activation of the active site and starts the depletion of
the PIPs on the membrane. If the VSD does not deactivate, the
subsequent depletion of PIPs leads the phosphatase domain to unbind
from the membrane, effectively turning off catalysis without changing the
activation state of the VSD. This feedback is driven by the phosphatase
domain interacting with the membrane via PIPs at the linker (Kohout
et al., 2010), the catalytic domain and potentially the C2 domain. Yellow
indicates PI(4,5)P2 in the membrane. Blue indicates unknown negatively
charged lipid in the membrane that could be one of the other substrates
for VSP: PI(3,4,5)P3 or PI(3,4)P2.
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Previous results have suggested a VSP feedback mechanism
wherein VSP is modulated by the very lipids it uses as substrates,
specifically suggesting that the linker between the VSD and the
catalytic domain mediates the feedback (Kohout et al., 2010).
Our results here indicate that the C2 domain is also involved in
modulation of activity through both direct and indirect interac-
tions. The direct interaction, Y522, modulates rates and voltage
dependence of catalysis. The indirect interactions, the cluster of
positive charges on the fourth CBL, also shift the voltage depen-
dence of catalysis. This shift may be due to interactions with
negatively charged lipids in the membrane and thus be part of
the feedback mechanism though perhaps not through PI(4,5)P2
(Figure 7). This model of VSP function suggests a coincident
detection mechanism in play as well as a feedback mechanism
where more than one lipid is detected between the linker and the
C2 to modulate the binding of the catalytic domain to the mem-
brane. Together, our results show that the C2 domain actively
contributes to VSP function because it modulates the rate and
voltage dependence of catalysis either through direct or indirect
mechanisms.
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